INOVIE (Groupe) in the news

Medical laboratories are widely offering non-prescription health checks, but experts warn that most are unnecessary and can lead to misinterpretations or delayed diagnoses without professional medical oversight.

The French medical biology sector's consolidation into a few large groups, driven by profit, has negatively impacted employee working conditions and patient care, leading to union calls for nationalization.

Gilles Treuil (Groupe Treuil), Thomas Hottier (Inovie), Philippe Croset (Groupe Fournier), and Jean Reignier (Comearth) were guests on the Pari ETI show presented by Patrice Bégay.

Thomas Hottier discussed Inovie's strategic role as a leading medical biology group during a BFM Business roundtable with other French mid-sized company CEOs.

Genbio-Inovie laboratory staff in Puy-de-Dôme went on strike to demand higher wages and protest deteriorating working conditions following the group's acquisition of the local network.

Medical analysis laboratory employees are striking on May 4th, demanding a 15% salary increase and improved working conditions amidst high profits and increased workload at groups like Inovie.

Medical laboratory employees from the Inovie group in Morbihan are striking on May 4, 2026, to demand higher wages and better working conditions.

Staff at several Inovie medical laboratories in Morbihan are striking to demand higher wages and better working conditions.

Inovie (Montpellier) is preparing to use its Marseille lab for cadmium screening, addressing a public health concern highlighted by Anses.

Inovie is modernizing its medical laboratory operations by deploying Dedalus's InVitro software suite to enhance performance and patient data management.

Inovie is modernizing its medical laboratory network through a large-scale deployment of Dedalus's InVitro digital software suite.

Inovie Biopyrénées has expanded its regional footprint by opening a new medical biology laboratory in Saint-Pierre-du-Mont.

Inovie CEO Thomas Hottier takes on a leadership role in the newly established French medical biology federation to influence industry regulation and funding.

Inovie Groupe has expanded its medical diagnostic network by acquiring Novabio and its 20 laboratories in southwestern France.

French medical diagnostics leader Inovie signed a ten-year partnership with Beckman Coulter to deploy advanced clinical chemistry and immunoassay testing technology.

Synlab has sold its majority stake in the BARLA medical biology laboratory network in southern France to Inovie Labosud.

A 10-year strategic partnership between INOVIE and Beckman Coulter aims to upgrade laboratory diagnostics through advanced immunoassay and chemistry testing platforms.

A major cyberattack on Inovie Labosud exposed medical data of 3.2 million French patients, including sensitive clinical information for one million, due to compromised external vendor credentials.

Inovie Labosud is dealing with a significant data breach potentially impacting over three million patients in southern France.

A major cyberattack targeted Inovie Labosud, compromising the administrative and medical data of thousands of patients in southern France.